%20(500%20%C3%97%20280%20px)%20(500%20x%20300%20px)%20(21).png "Department of Pharmaceuticals Launches RPTUAS Scheme")
- This scheme is a significant step in the government’s efforts to upgrade the technological capabilities of the pharmaceutical industry and align it with global standards.
- Here are some key features of the revised scheme:
- Broadened Eligibility Criteria: The eligibility for the PTUAS has been expanded beyond Micro, Small and Medium Enterprises to include any pharmaceutical manufacturing unit with a turnover of less than 500 crores that requires technology and quality upgradation.
- Flexible Financing Options: The scheme introduces more flexible financing options, emphasizing subsidies on a reimbursement basis, over the traditional credit-linked approach.
- Comprehensive Support for Compliance with New Standards: The scheme now supports a broader range of technological upgrades.
- Dynamic Incentive Structure: Pharmaceutical units with a certain average turnover for the last three years will be eligible for incentive subject to a maximum of Rs. 1.00 crore per unit.
- State Government Scheme Integration: The revised scheme allows integration with state government schemes, enabling units to benefit from additional top-up assistance.
- Enhanced Verification Mechanism: The scheme introduces a robust verification mechanism through a Project Management Agency.
- This scheme is expected to contribute to industry growth and compliance with global manufacturing standards.
- It underscores the Government’s commitment to supporting the critical pharmaceutical industry for the nation’s health and well-being.
Question:
Q.1 Who is eligible for the PTUAS under the revised scheme?a. Only Micro, Small and Medium Enterprises
b. Any pharmaceutical manufacturing unit with a turnover of less than 500 crores
c. Any pharmaceutical manufacturing unit with a turnover of more than 500 crores
d. All of the above
